Advancing mRNA-LNP characterization: innovative chromatographic approaches for next-generation therapeutics
No single analytical technique can comprehensively characterize complex biomolecules such as mRNA-LNP products. Charlotte Barker (Editor, Vaccine Insights) speaks to Jonathan Maurer (Postdoctoral Researcher, University of Geneva) about critical quality attributes for mRNA-lipid nanoparticle formulations, novel chromatographic methods for integrity and encapsulation efficiency evaluation, and the technical challenges of characterizing large RNA therapeutics.
Publication Details
- Journal
- Vaccine Insights
- Published
- 2025-10-21
- DOI
- https://doi.org/10.18609/vac.2025.040
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00